| Similar Articles |
|---|
 |
The Motley Fool
May 16, 2005
Jack Uldrich |
What Drives Accelrys? Is the scientific software company revving up, slowing down, or stuck in neutral? If you want to invest, tread carefully; limit orders are always a good idea in micro-cap land.   |
The Motley Fool
September 12, 2005
Jack Uldrich |
Nanotech's Promise Hits the Pedal The news that certain major chemical companies have climbed onboard offers additional support to Accelrys' claims that the consortium is creating software tools to speed up the design of new nanomaterials and devices. Investors, take note. |
Bio-IT World
Dec 2005/Jan 2006 |
News Blast Record Simulation... Merck-Ariadne Deal... Nano Group Forms... Database Debuts... |
Bio-IT World
October 2006 |
Briefs Kovac Joins Burrill... RNAi Nobel Prize... Hooray for Hood... ArQule Next... Initiative Accelerated... |
The Motley Fool
August 14, 2006
Jack Uldrich |
Accelrys Accelerates Help for the Life Sciences The company's new software tool can help design better drugs -- faster. This should help its software remain competitive, which, in turn, should hopefully allow the company's investors to see higher revenues in the quarters ahead. |
The Motley Fool
October 23, 2006
Jack Uldrich |
Is Microsoft on Drugs? If the company uses its new BioIT Alliance not simply to push its existing software, but also to better understand what biotech customers need and want, Microsoft's new drug habit could even provide its long-suffering shareholders a little high. |
Science News
February 5, 2005 |
Nanotech Facts The National Nanotechnology Initiative has a Web site devoted to "Nanotech Facts." |
The Motley Fool
January 9, 2006
Jack Uldrich |
More Big 2005 Nanotech News A recap roundup of big news in tiny tech continues: When Fortune 500 companies weren't partnering with or acquiring promising nanotechnology startups, many of them were investing heavily in their own nanotechnology-related research and development. Investors, take note. |
Bio-IT World
March 8, 2005
Salvatore Salamone |
Nano Poised for Liftoff First 'nano' technologies yield fruit in the biomedical lab and clinic with the promise of more to come. |
National Defense
October 2005
Grace Jean |
Moving Nanotechnology Research Into Market Remains a Challenge U.S. investments in nanotechnology have escalated into the billions of dollars in recent years. Yet moving the resulting discoveries and materials into the market remains one of the industry's toughest challenges. |
Chemistry World
October 9, 2012
Yan Yan |
Developing countries look to greater scientific cooperation Science and technology ministers from a number of developing countries have called for improved multinational cooperation to develop their respective science bases at the recent annual meeting of The Academy of Sciences for the Developing World. |
Bio-IT World
October 14, 2004
Robinson & Violino |
Strategic Insights: Global Positioning International Economic Development for biotech companies in search of a better location or international presence, countries in Asia and Europe are offering a host of incentives, including tax credits and reduced red tape. |
Bio-IT World
March 10, 2003
Mark D. Uehling |
Technology Overload Inundated with new IT tools and mountains of data, the pharmaceutical industry struggles to pull it all together. |
BusinessWeek
June 13, 2005
Arlene Weintraub |
Why Biotech Stocks Are Sedated Biotech might seem like a can't-miss investing opportunity but many investors are taking a pass on biotech, even amid bona fide scientific advances. |
The Motley Fool
May 16, 2005
Carl Wherrett |
The Next Tech Revolution At the smallest scale known to man lies the future of civilization. But what of investors? Should our portfolios take notice of this emerging, but as yet commercially unproven, technology? |
The Motley Fool
December 22, 2005
Jack Uldrich |
DuPont: The Truth Helps Nanotech The company's honesty provides a long-term insurance policy for developments in this promising field. Will DuPont's openness be rewarded in the marketplace? |
The Motley Fool
October 28, 2005
Jack Uldrich |
A New Nanotech Fund The PowerShares fund tries to make it easier to invest in nanotech. But the choice of companies could have been better. |
The Motley Fool
February 24, 2004
Wherrett & Yelovich |
Profiting From Nanotechnology Can you profit from this technology? An overview of what the science is and where opportunity may lie for investors. |
CFO
November 17, 2003
Peter Krass |
Nanotech What do you get when you mix chemistry, biology, physics, and computing? Something small, and huge. Nanotechnology is the science of manipulating individual atoms and molecules to create materials, devices, and systems with enhanced physical properties. |
IndustryWeek
September 1, 2008
Jill Jusko |
Nanotechnology's Commercial Impact: By The Numbers Nano-enabled products' value weigh in at $147 billion in 2007 |
IndustryWeek
May 1, 2007
Jill Jusko |
Nanotechnology Commercialization Efforts Continue As potential nanotech sales grow, so too does scrutiny. |
